Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors


How should advanced therapies be classified?

Written by | 14 Jun 2012 | All Medical News

Emerging uses of EMA Approved Drugs – by Gary Finnegan – The EMA has launched a public consultation on the classification of advanced therapies.

The Agency has published a reflection paper on the issue, setting out the legal basis for categorising medicines as advanced therapies and detailing the criteria for grouping new drugs as gene therapies, somatic-cell therapy, tissue-engineered medicines and combined medicines.

The paper also outlines the kinds of information applicants should provide when applying to have a medicine classified as an advanced therapy and it provides examples of borderline cases where scientific knowledge may be limited or evolving rapidly.

Advanced therapies are medicines that are made from genes and cells and may offer groundbreaking new treatment opportunities for many diseases and injuries.

As part of its role, the Agency’s Committee for Advanced Therapies (CAT) issues opinions on whether a medicine can be classified as an advanced therapy, and can therefore be assessed for a European Union-wide marketing authorisation via the European Medicines Agency.

Separately the EMA has launched a new e-learning course on the submission of medicines. The module will help to train industry executives on how to submit information to the agency in accordance with new EU pharmacovigilance legislation.

The modules are free to access and can be streamed live or downloaded. On completion of the e-learning course, participants are able to take a knowledge evaluation test. The Agency says that at least one user from each marketing-authorisation holder should be complete the course.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.


You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.